78 related articles for article (PubMed ID: 3226429)
1. Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities.
Lambert EH; Lennon VA
Muscle Nerve; 1988 Nov; 11(11):1133-45. PubMed ID: 3226429
[TBL] [Abstract][Full Text] [Related]
2. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
Kim YI
Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
[TBL] [Abstract][Full Text] [Related]
3. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
[TBL] [Abstract][Full Text] [Related]
4. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
Prior C; Lang B; Wray D; Newsom-Davis J
Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
[TBL] [Abstract][Full Text] [Related]
5. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.
Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M
Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
[TBL] [Abstract][Full Text] [Related]
7. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
Waterman SA; Lang B; Newsom-Davis J
Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
[TBL] [Abstract][Full Text] [Related]
8. [Neurogenic electromyographic activity in a patient with non-paraneoplasic Lambert-Eaton syndrome].
Lapergue B; Lefaucheur JP; Bourahoui A; Nordine T; Hosseini H; Créange A
Rev Neurol (Paris); 2007 Dec; 163(12):1227-31. PubMed ID: 18355470
[TBL] [Abstract][Full Text] [Related]
9. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
10. [A transferable "myasthenogenic" factor in the serum of patients with myasthenia gravis (author's transl)].
Toyka KV; Drachman DB; Pestronk A; Fischbeck H; Kao I
J Neurol; 1976 Jun; 212(3):271-80. PubMed ID: 58978
[TBL] [Abstract][Full Text] [Related]
11. Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor.
Newsom-Davis J; Murray N; Wray D; Lang B; Prior C; Gwilt M; Vincent A
Muscle Nerve; 1982; 5(9S):S17-20. PubMed ID: 6302493
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
13. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.
Fukunaga H; Engel AG; Lang B; Newsom-Davis J; Vincent A
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7636-40. PubMed ID: 6584877
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
15. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
[TBL] [Abstract][Full Text] [Related]
18. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome.
Tim RW; Sanders DB
Muscle Nerve; 1994 Sep; 17(9):995-1001. PubMed ID: 8065402
[TBL] [Abstract][Full Text] [Related]
19. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate.
Fukuoka T; Engel AG; Lang B; Newsom-Davis J; Vincent A
Ann Neurol; 1987 Aug; 22(2):200-11. PubMed ID: 3310854
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]